A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates

PHASE2TerminatedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Corneal Infiltrates

Interventions

DRUG

Moxifloxacin/dexamethasone phosphate ophthalmic solution

DRUG

Moxifloxacin ophthalmic solution 0.5%

DRUG

Dexamethasone phosphate solution, 0.1%

Trial Locations (1)

Contact Alcon Call Center at 1-888-451-3937, Fort Worth